Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
18 Novembro 2024 - 12:23PM
Spartan Capital Securities, LLC, a leading investment banking firm,
is pleased to announce its role as the sole placement agent in
Virpax Pharmaceuticals, Inc.'s (Nasdaq: VRPX) successful $5.0
million public offering of common stock and pre-funded warrants.
Virpax Pharmaceuticals, a preclinical-stage pharmaceutical
company focused on developing novel and proprietary drug delivery
systems across various pain indications, raised $5.0 million
through the sale of shares of common stock and pre-funded warrants
at a public offering price of $0.50 per share. The company intends
to use the proceeds for ongoing activities, including its planned
Investigational New Drug (IND) filing for its patented injectable
“local anesthetic” liposomal technology, Probudur™, aimed at
post-operative pain management. Additionally, funds will be
allocated to marketing and advertising services provided by IR
Agency LLC, as well as general corporate purposes.
“We are proud to have served as the sole placement agent in
Virpax Pharmaceuticals’ public offering,” said John Lowry, CEO of
Spartan Capital Securities. “Virpax’s innovative approach to
non-opioid pain management has the potential to address critical
unmet needs in post-operative pain care. We look forward to
continuing to support the company’s efforts to advance its
breakthrough technologies.”
Spartan Capital Securities was represented by Lucosky Brooker
LLP, with Scott Linksy, Xiaofan Zhang, and Raymond Ressy serving as
counsel. Virpax Pharmaceuticals was represented by Sichenzia Ross
Ference Carmel LLP, with Ross Carmel and Benjamin Sklar acting as
counsel.
About Spartan Capital Securities, LLC
Spartan Capital Securities, LLC is a premier full-service
investment banking firm offering a comprehensive range of advisory
services to institutional clients and high-net-worth individuals.
Known for its expertise in capital raising, strategic advisory, and
asset management, Spartan Capital delivers tailored solutions to
meet clients' financial goals.
For more information about Spartan Capital Securities, visit
www.spartancapital.com.
Contact:Spartan Capital Securities, LLC45 Broadway, 19th
FloorNew York, NY 10006investmentbanking@spartancapital.com
Virpax Pharmaceuticals (NASDAQ:VRPX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Virpax Pharmaceuticals (NASDAQ:VRPX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024